// App-Quantinova.ai

12633 2014 AHA : Coronary Artery Disease is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes, and Anemia: An Analysis of the TREAT Trial

Researchers

Presenter

  • Brian Claggett

Principal Investigators

  • Emmanuel A Burdmann

  • Marc A Pfeffer

  • Akshay S Desai

  • Peter Ivanovich

  • Reshma Kewalramani

  • Eldrin F Lewis

  • John JV McMurray

  • Kurt A Olson

  • Patrick Parfrey

  • Scott D Solomon

Medical Centers

  • Brigham & Women's Hospital, Boston, MA

  • Northwestern University, Chicago, IL

  • Cleveland Clinic Foundation, Cleveland, OH

  • University of Sao Paulo Medical School, Sao Paulo, Brazil

  • University of Glasgow, Glasgow, United Kingdom

  • Memorial University, St. John's, NF, Canada

Locations

  • United States

  • Canada

  • United Kingdom

  • Brazil

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Type 2 diabetes mellitus

  • Coronary Artery Disease

  • End stage renal disease

  • Chronic kidney disease

  • Diabetic nephropathy

  • Diabetes

  • Renal disease

  • Albuminuria

  • Anemia

Biomarkers

  • Creatinine

  • Human albumin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved